• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人工智能算法的肝癌切除术后复发监测模型。

A Model Based on Artificial Intelligence Algorithm for Monitoring Recurrence of HCC after Hepatectomy.

机构信息

State Key Laboratory of Oncology in South China, Guangzhou, China.

Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.

出版信息

Am Surg. 2023 May;89(5):1468-1478. doi: 10.1177/00031348211063549. Epub 2021 Dec 11.

DOI:10.1177/00031348211063549
PMID:34894786
Abstract

BACKGROUND

There is no satisfactory indicator for monitoring recurrence after resection of hepatocellular carcinoma (HCC). This retrospective study aimed to design and validate an HCC monitor recurrence (HMR) model for patients without metastasis after hepatectomy.

METHODS

A training cohort was recruited from 1179 patients with HCC without metastasis after hepatectomy between February 2012 and December 2015. An HMR model was developed using an AdaBoost classifier algorithm. The factors included patient age, TNM staging, tumor size, and pre/postoperative dynamic variations of alpha-fetoprotein (AFP). The diagnostic efficacy of the model was evaluated based on the area under the receiver operating characteristic curves (AUCs). The model was validated using a cohort of 695 patients.

RESULTS

In preoperative patients with positive or negative AFP, the AUC of the validation cohort in the HMR model was .8877, which indicated better diagnostic efficacy than that of serum AFP (AUC, .7348). The HMR model predicted recurrence earlier than computed tomography/magnetic resonance imaging did by 191.58 ± 165 days. In addition, the HMR model can predict the prognosis of patients with HCC after resection.

CONCLUSIONS

The HMR model established in this study is more accurate than serum AFP for monitoring recurrence after hepatectomy for HCC and can be used for real-time monitoring of the postoperative status in patients with HCC without metastasis.

摘要

背景

目前尚无满意的指标用于监测肝癌(HCC)切除后复发。本回顾性研究旨在设计并验证一种适用于肝癌切除术后无转移患者的 HCC 复发监测(HMR)模型。

方法

本研究纳入了 2012 年 2 月至 2015 年 12 月期间 1179 例肝癌切除术后无转移患者的资料。采用 AdaBoost 分类器算法建立 HMR 模型,模型中包含的因素有患者年龄、TNM 分期、肿瘤大小以及甲胎蛋白(AFP)的术前术后动态变化。根据受试者工作特征曲线(ROC)下面积(AUC)评估模型的诊断效能。使用另一组 695 例患者的数据对模型进行验证。

结果

在术前 AFP 阳性或阴性的患者中,验证队列中 HMR 模型的 AUC 为 0.8877,其诊断效能优于血清 AFP(AUC 为 0.7348)。HMR 模型比计算机断层扫描/磁共振成像早 191.58±165 天预测复发。此外,HMR 模型可预测 HCC 患者术后的预后。

结论

与血清 AFP 相比,本研究中建立的 HMR 模型更能准确地监测 HCC 患者肝切除术后的复发情况,可用于实时监测无转移 HCC 患者的术后状态。

相似文献

1
A Model Based on Artificial Intelligence Algorithm for Monitoring Recurrence of HCC after Hepatectomy.基于人工智能算法的肝癌切除术后复发监测模型。
Am Surg. 2023 May;89(5):1468-1478. doi: 10.1177/00031348211063549. Epub 2021 Dec 11.
2
Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.肝癌肝切除术后血清甲胎蛋白和甲胎蛋白-L3 的变化:预后意义。
Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):618-23. doi: 10.1016/s1499-3872(12)60234-3.
3
New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.新的列线图可预测术前血清甲胎蛋白阴性且接受根治性切除的肝细胞癌患者的复发情况。
J Surg Oncol. 2018 Jun;117(7):1540-1547. doi: 10.1002/jso.25046. Epub 2018 Mar 24.
4
Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection.甲胎蛋白 Lens culinaris agglutinin-reactive fraction 作为肝癌根治性切除术后预后和复发监测的标志物。
Ann Surg Oncol. 2011 Aug;18(8):2218-23. doi: 10.1245/s10434-011-1613-7. Epub 2011 Feb 20.
5
Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.用于预测肝细胞癌根治性切除术后早期复发的术前血清肝酶标志物。
Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):178-85. doi: 10.1016/s1499-3872(15)60353-8.
6
Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.术前血清甲胎蛋白(AFP)水平与肝癌(HCC)肝切除术后预后的相关性分析。
World J Surg Oncol. 2013 Aug 27;11:212. doi: 10.1186/1477-7819-11-212.
7
Serum metabolites may be useful markers to assess vascular invasion and identify normal alpha-fetoprotein in hepatocellular carcinoma undergoing liver resection: a pilot study.血清代谢物可作为评估血管侵犯和识别行肝切除术的肝细胞癌中正常甲胎蛋白的有用标志物:一项初步研究。
World J Surg Oncol. 2020 Jun 3;18(1):121. doi: 10.1186/s12957-020-01885-w.
8
Can IVIM help predict HCC recurrence after hepatectomy?IVIM 能否有助于预测肝癌切除术后的 HCC 复发?
Eur Radiol. 2019 Nov;29(11):5791-5803. doi: 10.1007/s00330-019-06180-1. Epub 2019 Apr 10.
9
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
10
[Impact of serum α-fetoprotein level on short-term recurrence after R0 resection in primary hepatocellular carcinoma].[血清甲胎蛋白水平对原发性肝细胞癌R0切除术后短期复发的影响]
Zhonghua Wai Ke Za Zhi. 2013 Jul;51(7):600-3.

引用本文的文献

1
Bridge Therapy before Liver Transplant for Advanced Hepatocellular Carcinoma.桥接治疗在肝移植治疗晚期肝细胞癌中的应用。
Medicina (Kaunas). 2024 Jun 20;60(6):1010. doi: 10.3390/medicina60061010.
2
Adjuvant ICIs Plus Targeted Therapies Reduce HCC Recurrence after Hepatectomy in Patients with High Risk of Recurrence.辅助免疫检查点抑制剂联合靶向治疗可降低复发风险高的肝癌患者肝切除术后的 HCC 复发率。
Curr Oncol. 2023 Jan 31;30(2):1708-1719. doi: 10.3390/curroncol30020132.
3
Impact of insurance type in postoperative emergency department utilization and clinical outcomes following ventral hernia repair (VHR).
保险类型对腹疝修补术(VHR)后急诊利用和临床结局的影响。
Surg Endosc. 2022 Dec;36(12):9416-9423. doi: 10.1007/s00464-022-09287-7. Epub 2022 May 18.